Abstract
Formoterol is a long acting β2-adrenoceptor agonist designed for the alleviation of the symptoms of asthma. This study examined the effects of 14 day administration of formoterol (200 μg/kg/day i.p.) on β1- and β2-adrenoceptors in guinea-pig cardiac and lung tissue. Quantitative autoradiography was used to measure changes in receptor density and organ bath studies determined alterations in functional response.
Formoterol treatment produced marked reductions of between 43% and 77% in β2-adrenoceptor density in all regions of the heart (atrioventricular node, bundle of His, right and left bundle branches, interventricular and interatrial septa, right and left atria, ventricles and apex) and lung (bronchial and vascular smooth muscle and parenchyma) (P < 0.01, n = 6). β1-Adrenoceptor density remained unchanged in all cardiac and lung regions. In functional studies (−)-isoprenaline was 4 fold less potent at causing relaxation of carbachol (1 μM) precontracted tracheal smooth muscle (pD2: control 8.49 ± 0.03, formoterol 7.91 ± 0.10, P < 0.001, n = 4), but formoterol treatment did not change the ability of (−)-isoprenaline to elicit a maximum response. The pKB values for ICI 118,551, 7.33 ± 0.08 in the control and 7.20 ± 0.01 in formoterol treated animals, were between those expected for β1- and β2-adrenoceptors suggesting involvement of both subtypes in the response. In spontaneously beating right atria and electrically paced left atria, tissues in which responses are largely mediated by β1-adrenoceptors, there was no significant change in responses to (−)isoprenaline (right atria pD2: control 8.45 ± 0.02; formoterol 8.42 ± 0.11; P = 0.77, n = 4) (left atria pD2: control 8.25 ± 0.03; formoterol 8.47 ± 0.08; P = 0.09, n = 4). In the presence of CGP 20712A (100 nM) the pKB values did not change with formoterol treatment (left atria: control 9.59 ± 0.12, formoterol 9.66 ± 0.12; P = 0.70, n = 4) (right atria: control 8.93 ± 0.11, formoterol 9.11 ± 0.07; P = 0.25, n = 4).
The doses and route of administration of formoterol used in this study differs from those used clinically. However, this study demonstrates that chrome formoterol administration produces selective down-regulation of β2-adrenoceptors in the lung and heart. The changes in the lung are accompanied by a shift to the right in the concentration-response curve to β-agonist stimulation with no change in the maximum response.
Similar content being viewed by others
References
Barnes PJ (1986) Neural control of human airways in health and disease. Am Rev Respir Dis 134:1289–1314
Barnes PJ (1989) A new approach to the treatment of asthma. N Engl J Med 321:1517–1527
Barnes PJ, Nadel JA, Skoogh B-E, Roberts JM (1983) Characterization of beta-adrenoceptor subtypes in canine smooth muscle by radioligand binding and physiological responses. J Pharmacol Exp Ther 225:456–461
Barnes PJ, Jacobs MM, Roberts JM (1984) Gluocorticoids preferably increase fetal alveolar beta-receptors: autoradiographic evidence. Pediatr Res 18:1191–1194
Bilski AJ, Halliday SE, Fitzgerald JD, Wade JC (1983) The pharmacology of a β2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 5:430–437
Boushey HA, Holtzman MJ, Sheller JR, Nadel JA (1980) Bronchial hyperreactivity. Am Rev Respir Dis 121:389–413
Böhm M, Gengenbach S, Hauck RW, Sunder-Plassmann L, Erdmann E (1991) Beta-adrenergic receptors and m-cholinergic receptors in human lung: Findings following in vivo and in vitro exposure to the β-adrenergic receptor agonist, terbutaline. Chest 100:1246–1253
Brodde OE, Brinkmarm M, Schemuth R, O'Hara N, Daul A (1985) Terbutaline-induced desensitization of human lymphocyte β2-adrenoceptors. J Clin Invest 76:1096–1101
Brodde OE, Petrasch S, Bauch HJ, Daul A, Gnadt M, Oefler, D, Michel MC (1992) Terbutaline-induced desensitization of β2-adrenoceptor in vivo function in humans: Attenuation by ketotifen. J Cardiovasc Pharmacol 20:434–439
Carstairs JR, Nimmo AJ, Barnes PJ (1984) Autoradiographic localisation of β-adrenoceptors in human lung. Eur J Pharmacol 103:189–190
Carstairs JR, Nimmo AJ, Barnes PJ (1985) Auto radiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 132:541–547
Carswell H, Nahorski SR (1983) β-Adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies. Br J Pharmacol 79:965–971
Conolly ME, Davies DS, Dollery CT, George DF (1971) Resistance to β-adrenoceptor stimulants (a possible explanation for the rise in asthma deaths). Br J Pharmacol 43:389–402
Decker N, Quennedey MC, Rouot B, Schwartz J, Velly J (1982) Effects of N-aralkyl substitution of β-agonists on α- and β-adrenoceptor subtypes: pharmacological studies and binding assays. J Pharm Pharmacol 34:107–112
De Monchey JR, Kauffman HE, Venge P, Koëter GH, Jansen HM, Sluiter HJ, De Vries K (1985) Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 131:373–376
Dooley DJ, Bittiger H, Reyman NC (1986) CGP 20712A: a useful tool for quantitating β1- and β2-adrenoceptors. Eur J Pharmacol 130:137–140
Dunnill MS (1960) The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 13:27–33
Elfellah MS, Reid JL (1990) Regulation of β-adrenoceptors in the guinea-pig left ventricle and skeletal muscle following chronic agonist treatment. Eur J Pharmacol 182:387–392
Emmerson J, Mackay D (1979) The zig-zag tracheal strip. J Pharm Pharmacol 31:798
Engels F, Carstairs JR, Barnes PJ, Nijkamp FP (1989) Autoradiographic localization of changes in pulmonary β-adrenoceptors in an animal model of atopy. Eur J Pharmacol 164:139–146
Faulds D, Hollingshead LM, Goa KL (1991) Formoterol: A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs 42:115–137
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blashko H, Muscholl E (eds) Handbook of experimental pharmacology, vol 33. Springer, New York, Berlin Heidelberg, pp 283–335
Furchgott RF, Wakade TD, Sorace RA, Stollak JS (1975) Occurrence of both β1 and β2 receptors in guinea-pig tracheal smooth muscle, and variation of the β1:β2 ratio in different animals [Abstract]. Fed Proc 34:794
Galant SP, Duriseti L, Underwood S, Insel PA (1978) Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med 299:933–936
Gatto C, Johnson MG, Seybold V, Kulik TJ, Lock JE, Johnson DE (1984) Distribution and quantitative developmental changes in guinea-pig pulmonary β-receptors. J Appl Physiol 57: 1901–1907
Gatto C, Green TP, Johnson MG, Marchessault RP, Seybold V, Johnson DE (1987) Localization of quantitative changes in pulmonary beta-receptors in ovalbumin-sensitized guinea-pigs. Am Rev Respir Dis 136:150–154
Goldie RG, Papadimitriou JM, Paterson JW, Rigby PJ, Spina D (1986a) Autoradiographic localization of β-adrenoceptors in pig lung using [125I]-iodocyanopinodolol. Br J Pharmacol 88:621–628
Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW (1986b) In vitro responsiveness of human asthmatic bronchus to carbachol, histamine β-adrenoceptor agonists and theophylline. Br J Clin Pharmacol 22:669–676
Goldie RG, Spina D, Rigby PJ, Paterson JW (1986c) Autoradiographic localisation of ascorbic acid-dependent binding sites for [125I]iodocyanopindolol in guinea-pig trachea. Eur J Pharmacol 124:179–182
Harvey JE, Tattersfield AE (1982) Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax 37:280–287
Henry PJ, Rigby PJ, Goldie RG (1990) Distribution of β1- and β2-adrenoceptors in mouse trachea and lung: a quantitative autoradiographic study. Br J Pharmacol 99:136–144
Ida H (1976) Cardiorespiratory activities of 3-formylamino-4-hydroxy-α —(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzylalcohol-hemifumarate (BD 40A) and some other β-adrenoceptor stimulants in conscious guinea-pigs. Arzneim Forsch 26:1337–1340
Jeppsson AB, Lofdahl CG, Waldeck B, Widmark E (1989) On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration. Pul Pharmacol 2:81–85
Kawakami Y (1984) Evaluation of therapeutic effects of formoterol, a β-adrenoceptor stimulating bronchodilator, on bronchial asthma - a multicentre double-blind single-dose study. Clin Evaluation 12:697–727
Kawakami Y, Noguchi E, Takahashi T, Shida T, Ito K (1983) Clinical trial of formoterol (BD 40A) on bronchial asthma. Yakuri to Chiryo. 11:3923–3934
Kompa AR, Molenaar P, Summers RJ (1992) Regulation of guineapig cardiac β-adrenoceptor subtypes after (−)-adrenaline and (−)-noradrenaline treatment. Mol Neuropharmacol 1:203–210
Lew R, Summers RJ (1985) Autoradiographic localization of β-adrenoceptor subtypes in guinea-pig kidney. Br J Pharmacol 85:341–348
Löfdahl CG, Chung KF (1991) Long acting β2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur Respir J 4:218–226
Löfdahl CG, Svedmyr N (1989) Formoterol fumarate, a new β2-adrenoceptor agonist. Allergy 44:264–271
Lulich KM, Goldie RG, Paterson JW (1988) Beta-adrenoceptor function in asthmatic bronchial smooth muscle. Gen Pharmacol 19:307–311
Maesen FPV, Smeets JJ, Gubbelmans HLL, Zweers PGMA (1990a) Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours. Chest 97:590–594
Maesen FPV, Smeets JJ, Gubbelmans HLL, Zweers PGMA (1990b) Formoterol in the treatment of nocturnal asthma. Chest 98:866–870
McAlpine LG, Thomson NC (1990) Prophylaxis of exercise-induced asthma with inhaled formoterol, a long acting β2-adrenergic agonist. Respir Med 84:293–295
McPherson GA, Malta E, Molenaar P, Raper C (1984) The affinity and efficacy of the selective β1-adrenoceptor stimulant R0363 at β1- and β2-adrenoceptor sites. Br J Pharmacol 82:897–904
Metzger WJ, Zavala D, Richerson HB, Moseley P, Iwamota P, Monick M, Sjoerdsma K, Hunninghake GW (1987) Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis 135:433–440
Molenaar P, Summers RJ (1987) Characterization of beta-1 and beta-2 adrenoceptors in guinea-pig atrium: Functional and receptor binding studies. J Pharmacol Exp Ther 241:1041–1047
Molenaar P, Canale E, Summers RJ (1987) Autoradiographic localization of beta-1 and beta-2 adrenoceptors in guinea-pig atrium and regions of the conducting region. J Pharmacol Exp Ther 241:1048–1064
Molenaar P, Russell FD, Shimada T, Summers RJ (1990a) Densitometric analysis of β1- and β2-adrenoceptors in guinea-pig atrioventricular conducting system. J Mol Cell Cardiol 22: 483–495
Molenaar P, Smolich JJ, Russell FD, McMartin LR, Summers RJ (1990b) Differential regulation of beta-1 and beta-2 adrenoceptors in gunea-pig atrioventricular conducting system after chronic (−)-isoproterenol infusion. J Pharmacol Exp Ther 255:393–400
Molenaar P, Kompa AR, Roberts SJ, Pak HS, Summers RJ (1992) Localization of (−)-[125I]cyanopindolol binding in guinea-pig heart: characteristics of non-β-adrenoceptor related binding in cardiac pacemaker and conducting regions. Neurosci Lett 136:118–122
Murphree SS, Saffitz JE (1988) Delineation of the distribution of β-adrenergic receptor subtypes in canine myocardium. Circ Res 63:117–125
Nerme V, Severne Y, Abrahamsson T, Vauquelin G (1985) Endogenous noradrenaline masks beta-adrenergic receptors in rat heart membranes via tight agonist binding. Biochem Pharmacol 34:2917–2922
Neve KA, McGongile P, Molinoff PB (1986) Quantitative analysis of the selectivity of radioligands for subtypes of beta-adrenergic receptors. J Pharmacol Exp Ther 238:46–53
O'Donnell SR, Wanstall JC (1979) The importance of choice of agonist in studies designed to predict β2: β1 adrenoceptor selectivity of antagonists from pA2 values on guinea-pig trachea and atria. Naunyn Schmiedeberg's Arch Pharmacol 308:183–190
Raaijmakers JAM, Van Rozen AJ, Terpstra GK, Wassink GA, Kreukniet J (1985) Autonomic receptor deficiencies in the pathogenesis of chronic obstructive lung disease. Prog Respir Res 19:152–158
Raaijmakers JAM, Beneker C, Dol R, De Ruiter-Bootsma AL (1987) Decreased bronchiolar epithelial β-adrenoceptor densities in patients with chronic obstructive lung disease. Cell Mol Biol 33: 515–518
Reed CE (1974) Abnormal automatic mechanisms in asthma. J Allergy Clin Immunol 53:34–41
Roets E, Burvenich C (1993) Effect of clenbuterol on β-adrenoceptors and adenylate cyclase activity in the smooth muscle and epithelium of the trachea of calves. Vet Quart 15:180–181
Spina D, Rigby PJ, Paterson JW, Goldie RG (1989) Autoradiographic localization of beta-adrenoceptors in asthmatic lung. Am Rev Respir Dis 140:1410–1415
Svedmyr N, Larsson SA, Thiringer GK (1976) Development of “resistance” in beta-adrenergic receptors of asthmatic patients. Chest 69:479–483
Szentivanyi A (1968) The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 42:203–232
Tashkin DP, Conolly ME, Deutsch RI, Hui KK, Littner M, Scarpace P, Abrass I (1982) Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Respir Dis 125:185–193
Tattersfield AE, Holgate ST, Harvey JE, Gribbin HR (1983) Is asthma due to partial beta-blockade of airways? Agents Actions [Suppl] 13:265–271
Tomioka K, Yamada T, Tachikawa S (1984) Effects of formoterol (BD 40A), a β-adrenoceptor stimulant, on isolated guinea-pig lung parenchymal strips and antigen-induced SRS-A release in rats. Arch Int Pharmacodyn 267:91–102
Tsoy AN, Cheltzov VV, Zaseyeva OV, Shilinsh V, Yashina LA (1990) Preventative effect of formoterol aerosol in exercise-induced bronchoconstriction. [Abstract] Eur Respir J [Suppl] 3:235s
Weber RW, Smith JA, Nelson HS (1982) Aerosolized terbutaline in asthmatics: development of subsensitivity with long-term administration. J Allergy Clin Immunol 70:417–422
Xue QF, Maurer R, Engel G (1983) Selective distribution of beta-and alpha1-adrenoceptors in rat lung visualized by autoradiography. Arch Int Pharmacodyn Ther 266:308–313
Young WS, Kuhar MJ (1979) A new method for receptor autoradiography: [3H]-Opioid receptors in rat brain. Brain Res 179:255–270
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kompa, A.R., Molenaar, P. & Summers, R.J. β-Adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting β2-adrenoceptor agonist formoterol. Naunyn-Schmiedeberg's Arch Pharmacol 351, 576–588 (1995). https://doi.org/10.1007/BF00170156
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00170156